Can You Take Quetiapine with Lorazepam?
A plain-English look at the major interaction between Quetiapine (Seroquel XR) and Lorazepam (ATIVAN Lorazepam 1mg tablet blister pack) — what it means, why it happens, and what to talk to your doctor or pharmacist about.
Taking Quetiapine (Seroquel XR) with Lorazepam (ATIVAN Lorazepam 1mg tablet blister pack) is a major drug interaction that should be avoided. Life-threatening respiratory depression, overdose, coma, and death. Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.
Not sure about your specific combination? Check it in the Drug Interaction Checker →
Key Takeaways
- Interaction severity: Major
- Risk: Life-threatening respiratory depression, overdose, coma, and death.
- Mechanism: Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.
- Quetiapine: S4 in Australia, moderate risk
- Lorazepam: S4 in Australia, moderate risk
- Claims action: Flag for immediate prescriber review. Document intervention in claim file.
Quetiapine vs Lorazepam at a Glance
| Property | Quetiapine | Lorazepam |
|---|---|---|
| Brand names | Seroquel XR, Tevatiapine XR, Quetia XR | ATIVAN Lorazepam 1mg tablet blister pack, ATIVAN Lorazepam 2.5mg tablet blister pack, ATIVAN lorazepam 1mg tablet bottle |
| Drug class | opioid | benzo |
| Risk level | moderate | moderate |
| TGA Schedule (AU) | S4 | S4 |
Why Is This Combination Dangerous?
Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.
Regulatory Guidance by Jurisdiction
Australia TGA / SIRA / WorkSafe
The TGA and Australian Medicines Handbook classify this as a major drug interaction requiring immediate intervention.
All Australian state workers compensation schemes (SIRA NSW, WorkSafe VIC, WorkCover QLD) flag concurrent opioid and benzodiazepine prescribing as high-risk. SIRA best practice guidelines explicitly recommend avoiding this combination except in exceptional circumstances with specialist oversight.
United Kingdom NICE / MHRA / FPM
NICE NG193 (Chronic Pain) recommends against initiating opioids for chronic primary pain. The Faculty of Pain Medicine (FPM) Opioids Aware guidelines strongly advise against concurrent opioid and benzodiazepine prescribing. For personal injury claims in the UK, this combination should be flagged for specialist review. Costs for medication review may be recoverable as a disbursement.
United States FDA / CDC / State WC
The FDA requires a Boxed Warning on all opioid and benzodiazepine products about the risks of concurrent use. The CDC Clinical Practice Guideline (2022) recommends clinicians avoid prescribing opioids and benzodiazepines concurrently whenever possible. Most state workers compensation drug formularies flag or restrict this combination.
What Claims Professionals Should Do
- Flag immediately as a high-risk prescribing pattern in the claim file
- Request urgent prescriber review with documented clinical justification for the combination
- Consider an independent medical examination if the prescriber cannot provide adequate justification
- Assess work capacity impact as the combination significantly increases sedation and impairment risk
- Document all interventions for audit trail and compliance purposes
- Check Reasonable and Necessary status for both medications against the compensable injury
Clinical reference
A clinical summary of Quetiapine and Lorazepam drawn from regulator advisories, national guidelines, and authoritative drug references. Read this if you want the deeper clinical picture before talking to your prescriber or pharmacist.
Severity assessment
Moderate. The concomitant use of lorazepam and quetiapine can lead to increased central nervous system (CNS) depression, resulting in excessive sedation, dizziness, confusion, and impaired coordination [1] [2] [3].
Mechanism (plain English)
Both lorazepam and quetiapine act on the central nervous system, but through different pathways. Lorazepam is a benzodiazepine that enhances the effect of gamma-aminobutyric acid (GABA), a neurotransmitter that calms brain activity, leading to sedative and anxiolytic effects. Quetiapine is an atypical antipsychotic that blocks several neurotransmitter receptors, including dopamine and serotonin, which contributes to its sedative and antipsychotic properties. When taken together, their combined CNS depressant effects are additive, meaning they amplify each other, leading to a greater degree of sedation and other CNS-related side effects. Additionally, some evidence suggests that quetiapine may enhance the CNS effects of lorazepam, and the mean oral clearance of lorazepam may be reduced by quetiapine, potentially increasing lorazepam levels in the body [3] [4] [5].
Evidence level
Regulator-flagged. Both the FDA labels for lorazepam and quetiapine, as well as the British National Formulary (BNF), highlight the risks associated with co-administration of CNS depressants [1] [2] [4].
Top regulator advisories (cite verbatim or close paraphrase)
- TGA (Australia): No specific public advisory for the lorazepam-quetiapine pair was found. However, the Australian Public Assessment Report for Quetiapine notes that "The mean oral clearance of lorazepam (2 mg, single dose) was reduced by 20 %" when co-administered with quetiapine [5].
- MHRA / NICE (UK): The British National Formulary (BNF) states that "Both Quetiapine and Lorazepam have effects on the CNS and can cause sedation, which might affect the ability to perform skilled tasks" [4].
- FDA / CDC (US): The FDA label for lorazepam warns about the concomitant use of benzodiazepines with other CNS depressants, stating it "may lead to potentially fatal respiratory depression" [2]. The FDA label for quetiapine indicates that quetiapine did not affect the single dose pharmacokinetics of lorazepam at 750 mg/day [1]. However, the general warning for CNS depressants from the lorazepam label is applicable.
- EMA (Europe): No specific EMA advisory for this exact pair was readily found within the scope of this research.
Clinical risk factors that elevate the danger
Patients at higher risk include the elderly, those with compromised respiratory function (e.g., COPD, sleep apnea), individuals with hepatic impairment, and those concurrently using other CNS depressants such as alcohol, opioids, or other sedatives. Rapid dose escalation of either medication can also increase the risk of adverse effects [2] [3] [6].
What a patient should be told
- Risk of severe drowsiness and breathing problems: Combining lorazepam and quetiapine can make you very sleepy, dizzy, confused, and can slow down your breathing to a dangerous level. Avoid driving or operating heavy machinery until you know how these medicines affect you.
- Do not stop suddenly: If you are taking these medications regularly, do not stop taking them abruptly without talking to your doctor or pharmacist. Suddenly stopping can lead to withdrawal symptoms, which can be serious.
- Watch for warning signs: Be aware of signs like extreme drowsiness, difficulty waking up, slow or shallow breathing, unusual dizziness, or confusion. If you experience these, seek medical attention immediately.
- Discuss alternatives: Talk to your doctor or pharmacist about all medications you are taking, including over-the-counter drugs, supplements, and herbal products. They can help assess your risk and discuss safer alternatives or dose adjustments.
- Urgent care triggers: If you or someone with you experiences severe difficulty breathing, unresponsiveness, or extreme confusion, seek urgent medical care or call emergency services immediately.
Top 3 sources (with full citation)
- U.S. Food and Drug Administration. (2022). SEROQUEL (quetiapine) tablets, for oral use [Prescribing Information]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020639s072lbl.pdf
- U.S. Food and Drug Administration. (2021). Ativan (lorazepam) Tablets [Prescribing Information]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017794s048lbl.pdf
- Drugs.com. (n.d.). Lorazepam and Quetiapine Drug Interactions. Retrieved June 1, 2026, from https://www.drugs.com/drug-interactions/lorazepam-with-quetiapine-1488-0-1979-0.html
Notes for the reviewing pharmacist
While the quetiapine FDA label states no pharmacokinetic effect on lorazepam, the pharmacodynamic interaction leading to additive CNS depression is well-established and clinically significant. The TGA AUSPAR for quetiapine did note a 20% reduction in lorazepam clearance, which could contribute to increased lorazepam levels and enhanced CNS effects. This discrepancy highlights the importance of considering both pharmacokinetic and pharmacodynamic interactions. Clinicians should be particularly vigilant in elderly patients and those with respiratory or hepatic compromise. Patient education should emphasize the risks of profound sedation and respiratory depression, and the importance of not discontinuing medication abruptly. The potential for misuse and abuse of lorazepam, a benzodiazepine, should also be considered in the overall risk assessment.
Source metadata JSON
{
"pair": "lorazepam + quetiapine",
"severity": "Moderate",
"evidence_level": "Regulator-flagged",
"source_urls": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020639s072lbl.pdf;https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017794s048lbl.pdf;https://www.drugs.com/drug-interactions/lorazepam-with-quetiapine-1488-0-1979-0.html;https://bnf.nice.org.uk/interactions/quetiapine/;https://www.tga.gov.au/sites/default/files/auspar-seroquel.pdf;https://www.goodrx.com/lorazepam/lorazepam-interactions?srsltid=AfmBOoqtF4Fib5082qv8FevkFGKyn84XSe1Ota9GKzPNZfjFpJAqeSrK;https://mountainvalleyrecovery.com/what-drugs-should-you-not-take-with-lorazepam/;https://www.droracle.ai/articles/716153/how-to-manage-an-elderly-male-patient-with-a;https://www.droracle.ai/articles/712393/what-are-the-potential-interactions-between-buspar-buspirone-lorazepam;https://link.springer.com/article/10.2165/00128415-200812040-00070"
}Sources used in this brief (10)
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020639s072lbl.pdf
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/017794s048lbl.pdf
- https://www.drugs.com/drug-interactions/lorazepam-with-quetiapine-1488-0-1979-0.html
- https://bnf.nice.org.uk/interactions/quetiapine/
- https://www.tga.gov.au/sites/default/files/auspar-seroquel.pdf
- https://www.goodrx.com/lorazepam/lorazepam-interactions?srsltid=AfmBOoqtF4Fib5082qv8FevkFGKyn84XSe1Ota9GKzPNZfjFpJAqeSrK
- https://mountainvalleyrecovery.com/what-drugs-should-you-not-take-with-lorazepam/
- https://www.droracle.ai/articles/716153/how-to-manage-an-elderly-male-patient-with-a
- https://www.droracle.ai/articles/712393/what-are-the-potential-interactions-between-buspar-buspirone-lorazepam
- https://link.springer.com/article/10.2165/00128415-200812040-00070
Check this medication against your full medication list
Check all interactions for Quetiapine and Lorazepam across your claimant's full medication list.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Related Resources
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.